Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice

Vaccine

Volumn 22, Issue 15-16, 2004, Pages 1868-1872

  Basso, B ^a   Cervetta, L ^a   Moretti, E ^a   Carlier, Y ^b   Truyens, C ^b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Chagas disease; Cytokines; Nitric oxide; Protection; Trypanosoma cruzi; Trypanosoma rangeli; Vaccination

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; NITRIC OXIDE; PROTEIN P40; PROTEIN P53; PROTOZOAL VACCINE; TRYPANOSOMA RANGELI VACCINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; IMMUNE RESPONSE; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PROTOZOAL INFECTION; TRYPANOSOMA CRUZI; VACCINATION;

ANIMALS; CHAGAS DISEASE; CYTOKINES; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PROTOZOAN VACCINES; RECEPTORS, TUMOR NECROSIS FACTOR; SURVIVAL ANALYSIS; TRYPANOSOMA; TRYPANOSOMA CRUZI; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION;

EID: 2342455199     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.013     Document Type: Article

References (47)

1. Carlier Y, Pinto Dias JC, Ostermayer Luquetti A, Hontebeyrie M, Torrico F, Truyens C. Trypanosomiase américaine ou Maladie de Chagas. In: Editions Scientifiques et médicales Elsevier SAS tdr, editors. Encycl Méd Chir Paris 2002;8-505-A-20:21.
2. Garg N., Tarleton R.L. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70(10):2002;5547-5555
3. Planelles L., Thomas M.C., Alonso C., Lopez M.C. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 69(10):2001;6558-6563
4. Wrightsman R.A., Manning J.E. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi. Vaccine. 18(14):2000;1419-1427
5. Araujo Z., El Bouhdidi A., Heremans H., Van Marck E., Castes M., Carlier Y. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response. Vaccine. 17(7-8):1999;957-964
6. Costa F., Franchin G., Pereira-Chioccola V.L., Ribeirao M., Schenkman S., Rodrigues M.M. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine. 16(8):1998;768-774
7. Taibi A., Espinoza A.G., Ouaissi A. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease. Immunol. Lett. 48(3):1995;193-200
8. Basombrio M.A., Segura M.A., Mora M.C., Gomez L. Field trial of vaccination against American trypanosomiasis (Chagas' disease) in dogs. Am. J. Trop. Med. Hyg. 49(1):1993;143-151
9. Basso B., Moretti E.R., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Med. Hyg. 44(4):1991;413-419
10. Introini M.V., Basso B., Moretti E.R. Experimental Chagas disease. I. Study of different immunization conditions in the infection course. Bol. Chil. Parasitol. 53(3-4):1998;45-51
11. Stevens J.R., Teixeira M.M., Bingle L.E., Gibson W.C. The taxonomic position and evolutionary relationships of Trypanosoma rangeli. Int. J. Parasitol. 29(5):1999;749-757
12. Buschiazzo A., Campetella O., Frasch A.C. Trypanosoma rangeli sialidase: cloning expression and similarity to T. cruzi trans-sialidase. Glycobiology. 7(8):1997;1167-1173
13. Guhl F., Marinkelle C.J. Antibodies against Trypanosoma cruzi in mice infected with T. rangeli. Ann. Trop. Med. Parasitol. 76(3):1982;361
14. Cervetta L., Moretti E.R., Basso B. Experimental Chagas'disease: the protection induced by immunization with Trypanosoma rangeli is associated with down-regulation of IL-6, TNFa and IL-10 synthesis. Acta Parasitol. 47(1):2002;73-78
15. Basso B., Moretti E.R., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Med. Hyg. 44(4):1991;413-419
16. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114(2):1997;103-110
17. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175(1):1992;169-174
18. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67(11):1999;5579-5586
19. Basso B., Moretti E.R., Dominguez M. Culture of Trypanosoma cruzi in a monophasic medium with aeration to obtain antigens. Medicina (B Aires). 40(4):1980;428-432
20. Basso B., Moretti E.R., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Med. Hyg. 44(4):1991;413-419
21. Pizzi T. La inmunología de la enfermedada de Chagas 1957. Universidad de Chile, Santiago de Chile.
22. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67(11):1999;5579-5586
23. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67(11):1999;5579-5586
24. Granger D.L., Taintor R.R., Boockvar K.S., Hibbs J.B. Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 268:1996;142-151
25. 15N ]nitrate in biological fluids Anal. Biochem. 126(1):1982;131-138
26. Abrahamsohn I.A., Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84(2):1996;231-244
27. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114(2):1997;103-110
28. Reed S.G. Immunology of Trypanosoma cruzi infections. Chem. Immunol. 70:1998;124-143
29. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175(1):1992;169-174
30. Ismail N., Olano J.P., Feng H.M., Walker D.H. Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol. Lett. 207(2):2002;111-120
31. Castanos-Velez E., Maerlan S., Osorio L.M., Aberg F., Biberfeld P., Orn A., et al. Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect. Immun. 66(6):1998;2960-2968
32. Revelli S., Didoli G., Roggero E., Moreno H., Bernabo J., Wietzerbin J., et al. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma. Cytokines Cell Mol. Ther. 4(3):1998;153-159
33. Martins G.A., Cardoso M.A., Aliberti J.C., Silva J.S. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 63(2):1998;113-120
34. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155(8):1995;3955-3963
35. al Ramadi B.K., Meissler J.J. Jr., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22(9):1992;2249-2254
36. Basso B., Moretti E.R., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Med. Hyg. 44(4):1991;413-419
37. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114(2):1997;103-110
38. Antunez M.I., Cardoni R.L. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol. Lett. 79(3):2001;189-196
39. Muller U., Kohler G., Mossmann H., Schaub G.A., Alber G., Di Santo J.P., et al. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J. Immunol. 167(6):2001;3346-3353
40. Meyer Zum B.C., Cramer S., Trumpfheller C., Fleischer B., Frosch S. Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol. 110(3):1997;378-385
41. Fernandez-Botran R., Chilton P.M., Ma Y. Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv. Immunol. 63:1996;269-336
42. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67(11):1999;5579-5586
43. Rivera M.T., Marques D.A., Lucas R., Deman J., Truyens C., Defresne M.P., et al. High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring. Infect. Immun. 63(2):1995;591-595
44. Jacobs F., Dubois C., Carlier Y., Goldman M. Administration of anti-CD3 monoclonal antibody during experimental Chagas' disease induces CD8+ cell-dependent lethal shock. Clin. Exp. Immunol. 103(2):1996;233-238
45. Truyens C., Torrico F., Lucas R., De Baetselier P., Buurman W.A., Carlier Y. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67(11):1999;5579-5586
46. Chandrasekar B., Melby P.C., Troyer D.A., Colston J.T., Freeman G.L. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. Am. J. Pathol. 152(4):1998;925-934
47. Basso B., Moretti E.R., Vottero-Cima E. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice. Am. J. Trop. Med. Hyg. 44(4):1991;413-419